The Fixed Phage technology irreversibly binds phage to almost any surface. This immobilisation allows phage delivery to targeted locations, extending the antibacterial activity of natural phage from days to years.
Location: United Kingdom, Scotland, Glasgow
Employees: 11-50
Total raised: $3.33M
Founded date: 2010
Investors 1
| Date | Name | Website |
| - | TRI Capita... | tricapital... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 18.03.2021 | - | $3.33M | - |